Christopher Ryan Sullivan's Insider Trades & SAST Disclosures
Christopher Ryan Sullivan's most recent trade in Avalo Therapeutics Inc was a trade of 163,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher Ryan Sullivan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 163,000 | 163,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 186,700 | 186,700 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 72,600 | 72,600 | - | - | Restricted Stock Units | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.42 per share. | 09 Jun 2023 | 511 | 1,262 | - | 3.4 | 1,748 | Common Stock |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 10 Dec 2021 | 955 | 9,004 | - | 1.6 | 1,499 | Common Stock |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 10 Dec 2020 | 5,095 | 8,049 | - | 2.3 | 11,606 | Common Stock |
|
Avalo Therapeutics Inc
|
Christopher Ryan Sullivan | Interim CFO | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 10 Jun 2020 | 2,954 | 2,954 | - | 2.3 | 6,729 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges